Stay updated on Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No substantive content changes detected. The page appears the same aside from minor visual/layout adjustments.
    Difference
    0.1%
    Check dated 2026-04-03T19:24:27.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    No detectable content changes between the old and new screenshots; the study details, eligibility criteria, and outcomes sections appear consistent.
    Difference
    0.1%
    Check dated 2026-03-27T13:23:40.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows a new document revision labeled v3.5.0 and removes the earlier v3.4.3 revision, indicating updated study documents are available.
    Difference
    0.1%
    Check dated 2026-03-20T07:39:26.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Results for the Phase I/II study of anti-CD3 x anti-HER2/Neu BATs with Pembrolizumab in metastatic breast cancer were posted, detailing dose-limiting toxicities, response rates, survival metrics, and immune monitoring data. Related study documents, including the Study Protocol and Informed Consent Form, were added.
    Difference
    3%
    Check dated 2026-03-05T23:26:40.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 on the page; there are no visible changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T07:33:53.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No user-visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-02-05T05:52:24.000Z thumbnail image

Stay in the know with updates to Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.